Queen Maria launches START LONGEVITY genetic test for preventive medicine

Queen Maria, a Romanian health company, launched START LONGEVITY, a genetic test aimed at personalized preventive medicine. The test claims to assess individual aging and disease risk based on DNA, though clinical validity and utility remain unverified. This marks a commercial expansion into direct-to-consumer genetic testing in Romania, with implications for healthcare personalization and regulatory oversight.